ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Debt / Equity
- 2026-06-30: Debt/Equity Ratio 0.
- 2026-03-31: Debt/Equity Ratio 0.6.
- 2025-12-31: Debt/Equity Ratio 0.6.
- 2025-09-30: Debt/Equity Ratio 0.64.
Complete source-backed debt/equity ratio history.
- Available history
- 2023-09-30 to 2026-06-30
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2026-06-30 | 0 |
| 2026-03-31 | 0.6 |
| 2025-12-31 | 0.6 |
| 2025-09-30 | 0.64 |
| 2025-06-30 | 0.74 |
| 2025-03-31 | 0.7 |
| 2024-12-31 | 0.66 |
| 2023-09-30 | 0.36 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2025-12-31 | 0.6 |
| 2024-12-31 | 0.66 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |